Next Article in Journal
GOF Mutant p53 in Cancers: A Therapeutic Challenge
Previous Article in Journal
Challenges and Learning Curves in Adopting TaTME and Robotic Surgery for Rectal Cancer: A Cusum Analysis
Previous Article in Special Issue
Comment on Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”

by
Vesna Kesić
1,2,*,
Pedro Vieira-Baptista
3,4 and
Colleen K. Stockdale
5
1
Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia
2
Clinic for Obstetrics and Gynecology, University Clinical Center of Serbia, 11000 Belgrade, Serbia
3
Lower Genital Tract Unit, Centro Hospitalar de São João, 4200-319 Porto, Portugal
4
Hospital Lusíadas Porto, 4200-319 Porto, Portugal
5
Department of Obstetrics & Gynecology, Vulvar Vaginal Disease and Colposcopy Clinics, University Iowa Healthcare, Iowa City, IA 52242, USA
*
Author to whom correspondence should be addressed.
Cancers 2022, 14(20), 5088; https://doi.org/10.3390/cancers14205088
Submission received: 3 October 2022 / Accepted: 9 October 2022 / Published: 18 October 2022
(This article belongs to the Special Issue Recent Advances in Vulvar Cancer)
We thank you and your co-authors for the comment [1] on our article “Early Diagnostics of Vulvar Intraepithelial Neoplasia” published in Cancers 2022, 14, 1822 [2]. It is a pleasure to see that our article drew attention, particularly from the side of dermatologists. Vulvar pathology, indeed, comprises the spectrum of different conditions and diseases that require a multidisciplinary approach involving gynecologists, dermatologists, and pathologists.
Dermoscopy is without doubt an extremely useful diagnostic tool in the evaluation of pigmented lesions on vulvar surface, particularly in suspicion of melanocitic lesions. However, dermoscopy is not available to non-dermatologists. In gynecological practice, whenever the suspicion of melanoma is raised, dermatologists are necessarily involved into a team. Additionally, most of the patients with dermatoses are sent to dermatologists who decide if dermoscopy or confocal microscopy would be appropriate, particularly for non-melanocitic lesions.
Our article is focused to squamous vulvar intraepithelial neoplasia (VIN). Dermoscopy does help differentiating infective and inflammatory conditions of the vulva and aids in avoiding unnecessary biopsies. However, VIN has a specific, most often easily recognizable vulvoscopic appearance, and since its capacity for progression to cancer is of utmost importance, biopsy or local excision are essential. Pigmented VIN lesions are not difficult to differ from melanoma, and thus dermoscopy and confocal microscopy are not routinely used for the diagnosis of VIN. They are addressed from time to time, but not enough evidence was ever shown that dermoscopy and confocal microscopy should lead to the recommendation of using it in gynecological clinical practice.
Regardless, your comment is greatly appreciated. It is an invaluable addition to Barisani’s [3] and Vaccari’s [4] articles, which together with a few other articles published by dermatologists, particularly the one prepared by Kavita and Deeksha [5], emphasize the need for closer cooperation between gynecologists and dermatologists in management of vulvar diseases.

Author Contributions

V.K.: writing—original draft preparation; P.V.-B. and C.K.S.: writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. De Giorgi, V.; Magnaterra, E.; Magliulo, M.; Silvestri, F.; Venturi, F.; Zuccaro, B.; Colombo, J.; Trane, L. Comment on Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822. Cancers 2022, 14, 5087. [Google Scholar] [CrossRef]
  2. Kesić, V.; Vieira-Baptista, P.; Stockdale, C.K. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822. [Google Scholar] [CrossRef]
  3. Barisani, A.; Dika, E.; Fanti, P.A.; De Iaco, P.; Tosti, G.; Patrizi, A.; Vaccari, S. Dermoscopic findings of vulvar intraepithelial neoplasia: A series of four cases. Br. J. Dermatol. 2017, 176, 227–230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Vaccari, S.; Barisani, A.; Preti, E.P.; Dika, E.; Fanti, P.A.; Patrizi, A.; Tosti, G. Dermoscopic features of pigmented vulvar intraepithelial neoplasia. Clin. Exp. Dermatol. 2018, 43, 63–65. [Google Scholar] [CrossRef] [PubMed]
  5. Kavitha, A.; Deeksha, P. Vulvar premalignancies—A dermatologist’s perspective. J. Ski. Sex. Transm. Dis. 2022, in press. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kesić, V.; Vieira-Baptista, P.; Stockdale, C.K. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”. Cancers 2022, 14, 5088. https://doi.org/10.3390/cancers14205088

AMA Style

Kesić V, Vieira-Baptista P, Stockdale CK. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”. Cancers. 2022; 14(20):5088. https://doi.org/10.3390/cancers14205088

Chicago/Turabian Style

Kesić, Vesna, Pedro Vieira-Baptista, and Colleen K. Stockdale. 2022. "Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”" Cancers 14, no. 20: 5088. https://doi.org/10.3390/cancers14205088

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop